Abstract
Background: Diabetes is a complicated disease requires continuous clinical care, to govern blood sugar.
Aim: To decides the impact of management of L carentin to diabetics at the lipid profile.
Methods: This study turned into performed on 120 diabetic Patients had been decided on from endocrinology and diabetes, inside decided on standards. The Patients distributed into three Strata (1st Strata of healthy population and two Strata of patients with diabetes who were on metformin and glibenclamide, one Strata took a L carnitine in a dose of 1000 mg TDS and a Strata dealing with a placebo for a period of ninety days).
Results: It is observed those who are on Lcarnitine, confirmed a large discount (p<0.05) with inside the triglyceride level, at the same time as no large adjustments had been located withinside the level of cholesterol and HDL and LDL.
Conclusion: These study outcomes that management of L carentin improved profile of lipid in type-2-diabetic Patients.